SRC and acute lymphoblastic leukemia: In addition, in acute lymphoblastic leukemia (ALL), patients with high levels of phosphorylated Src were more sensitive to the Hsp90 inhibitor NVP-BEP800 compared to those with low phosphorylated Src (Mshaik et al., 2021), suggesting Src phosphorylation may serve as a predictive biomarker.